HopeStage
Back to all studies
WithdrawnNCT03244852

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

Observational studyAges 21–64United States
The study in practice

Understand this study

Who could participate?

This study is for people with OCD. Listed age limits: 21 years to 64 years. Other eligibility criteria apply.

Listed locations
CharlestownSee all locations and recruitment

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 15, 2017
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
United States
Age range
From 21 Years to 64 Years
Official registry ID
NCT03244852
Official title
Show the full official title

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Withdrawn

Charlestown

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who can participate?

This study is for people with OCD. Listed age limits: 21 years to 64 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies